THE PIPELINE CRISIS (PharmaBiz)
Global pharmaceutical industry is facing, perhaps, one of the worst ever crises today. This industry thrives on a steady stream of new molecules from its research pipelines and their success as blockbusters in the market place.

PLC Systems Receives FDA Permission to Begin RenalGuard(TM) Investigational Study (RedNova)
FRANKLIN, Mass., Oct. 24 /PRNewswire-FirstCall/ -- PLC Systems Inc. , a company focused on innovative cardiac and vascular medical device-based technologies, announced today that the U.S.

Novartis: Gleevec gains approval for five more indications (Pharmaceutical Business Review)
Novartis Gleevec has now garnered simultaneous approval for the treatment of one solid tumor and four rare blood disorders. However, given the relatively small patient population groups within these diseases, expansion into these indications is unlikely to significantly enhance Gleevec s sales.